Explore more publications!
Health Wire Syria
Got News to Share?

Health Wire Syria: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Syria.

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

Press releases published on February 11, 2026

High Survival Rates With Ryoncil® in EIND Program Emphasize Importance of Earlier Use in Both Children and Adults With SR-aGvHD
Feb. 11, 2026

High Survival Rates With Ryoncil® in EIND Program Emphasize Importance of Earlier Use in Both Children and Adults With SR-aGvHD

Indeterminate GlobeNewswire
Tania Khaazal to Launch Groundbreaking Program "Cut-off Culture: The New Rules of Family Repair" in March 2026
Feb. 11, 2026

Tania Khaazal to Launch Groundbreaking Program "Cut-off Culture: The New Rules of Family Repair" in March 2026

Indeterminate GlobeNewswire
Java Burn Drops Product Information Updated as Consumer Interest in Liquid Coffee Supplement Options for Weight Management Grows in 2026
Feb. 11, 2026

Java Burn Drops Product Information Updated as Consumer Interest in Liquid Coffee Supplement Options for Weight Management Grows in 2026

Indeterminate GlobeNewswire
Biogen Announces Board Chair Transition
Feb. 11, 2026

Biogen Announces Board Chair Transition

Indeterminate GlobeNewswire
Etienna Bio, Inc. Announces Formation of Scientific Advisory Board with Renowned UMass Chan Leaders
Feb. 11, 2026

Etienna Bio, Inc. Announces Formation of Scientific Advisory Board with Renowned UMass Chan Leaders

Indeterminate GlobeNewswire
RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
Feb. 11, 2026

RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

Indeterminate GlobeNewswire
Regeneron Announces Investor Conference Presentations
Feb. 11, 2026

Regeneron Announces Investor Conference Presentations

Indeterminate GlobeNewswire
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Feb. 11, 2026

BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Universe Pharmaceuticals INC Announces Effective Date of Dual-Class Share Structure
Feb. 11, 2026

Universe Pharmaceuticals INC Announces Effective Date of Dual-Class Share Structure

Indeterminate GlobeNewswire
Vaxcyte Doses First Participants in OPUS-3 Phase 3 Trial Evaluating VAX-31 in Adults Previously Vaccinated with Lower-Valency Pneumococcal Vaccines
Feb. 11, 2026

Vaxcyte Doses First Participants in OPUS-3 Phase 3 Trial Evaluating VAX-31 in Adults Previously Vaccinated with Lower-Valency Pneumococcal Vaccines

Indeterminate GlobeNewswire
Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Updates on Tuesday, February 24, 2026
Feb. 11, 2026

Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Updates on Tuesday, February 24, 2026

Indeterminate GlobeNewswire
Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results
Feb. 11, 2026

Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
Feb. 11, 2026

Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire
Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
Feb. 11, 2026

Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

Indeterminate GlobeNewswire
Tectonic Therapeutic to Host Virtual KOL Event and Discussion of TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia, on February 24, 2026
Feb. 11, 2026

Tectonic Therapeutic to Host Virtual KOL Event and Discussion of TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia, on February 24, 2026

Indeterminate GlobeNewswire
Ascendis Pharma Reports Fourth Quarter and Full-Year 2025 Financial Results
Feb. 11, 2026

Ascendis Pharma Reports Fourth Quarter and Full-Year 2025 Financial Results

Indeterminate GlobeNewswire
Medical Informatics Corp. (MIC) Welcomes Danielle Russella to Board of Directors
Feb. 11, 2026

Medical Informatics Corp. (MIC) Welcomes Danielle Russella to Board of Directors

Indeterminate GlobeNewswire
Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA
Feb. 11, 2026

Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA

Indeterminate GlobeNewswire
MemoTril Product Information Updated as Consumer Interest in Brain Health and Cognitive Support Supplement Options Grows in 2026
Feb. 11, 2026

MemoTril Product Information Updated as Consumer Interest in Brain Health and Cognitive Support Supplement Options Grows in 2026

Indeterminate GlobeNewswire
Deep Origin Congratulates Isomorphic Labs on Catching Up
Feb. 11, 2026

Deep Origin Congratulates Isomorphic Labs on Catching Up

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions